AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 79 filers reported holding AVEO PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $9,000 | -30.8% | 566 | -65.4% | 0.00% | – |
Q3 2022 | $13,000 | +30.0% | 1,636 | +4.5% | 0.00% | – |
Q2 2022 | $10,000 | -16.7% | 1,565 | -28.5% | 0.00% | – |
Q1 2022 | $12,000 | +9.1% | 2,190 | -10.1% | 0.00% | – |
Q4 2021 | $11,000 | 0.0% | 2,435 | +50.8% | 0.00% | – |
Q3 2021 | $11,000 | 0.0% | 1,615 | -1.5% | 0.00% | – |
Q2 2021 | $11,000 | -21.4% | 1,640 | -13.9% | 0.00% | – |
Q1 2021 | $14,000 | +100.0% | 1,904 | +56.1% | 0.00% | – |
Q4 2020 | $7,000 | +250.0% | 1,220 | +269.7% | 0.00% | – |
Q3 2020 | $2,000 | 0.0% | 330 | -23.3% | 0.00% | – |
Q2 2020 | $2,000 | 0.0% | 430 | 0.0% | 0.00% | – |
Q1 2020 | $2,000 | – | 430 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AIGH Capital Management LLC | 2,739,255 | $22,544,000 | 7.01% |
Worth Venture Partners, LLC | 685,026 | $5,638,000 | 3.45% |
NEA Management Company, LLC | 3,952,957 | $32,533,000 | 1.62% |
Birchview Capital, LP | 140,000 | $1,152,000 | 0.81% |
Rubric Capital Management LP | 1,664,667 | $13,700,000 | 0.69% |
EAM Investors, LLC | 380,691 | $3,133,000 | 0.68% |
GLOBEFLEX CAPITAL L P | 368,520 | $3,033,000 | 0.52% |
X-Square Capital, LLC | 92,283 | $759,000 | 0.48% |
EAM Global Investors LLC | 211,759 | $1,743,000 | 0.46% |
J. Goldman & Co LP | 656,161 | $5,400,000 | 0.26% |